Quantitative structure-activity relationship study of recently synthesized 1,4-dihydropyridine calcium channel antagonists. Application of the Hansch analysis method

Archiv der Pharmazie

Volumn 335, Issue 10, 2002, Pages 472-480

  Hemmateenejad, Bahram ^a   Miri, Ramin ^b   Akhond, Morteza ^a   Shamsipur, Mojtaba ^c  

^a SHIRAZ UNIVERSITY   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c RAZI UNIVERSITY   (Iran)

Author keywords

Calcium channel antagonist activity; Hansch analysis; Nifedipine analogs; QSAR

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; 4 (1 METHYL 5 METHYLSULFONYL 2 IMIDAZOLYL) DERIVATIVE; 4 (1 METHYL 5 NITRO 2 IMIDAZOLYL) DERIVATIVE; 4 (5 PHENYL 2 IMIDAZOLYL) DERIVATIVE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; IMIDAZOLE DERIVATIVE; METHYLSULFONYLIMIDAZOLE DERIVATIVE; NIFEDIPINE; NIFEDIPINE DERIVATIVE; NITROIMIDAZOLE DERIVATIVE; PHENYLIMIDAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; DRUG SYNTHESIS; GUINEA PIG; HYDROPHOBICITY; ILEUM; INTESTINE CELL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ANIMALS; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; GUINEA PIGS; ILEUM; LINEAR MODELS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036962246     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.200290001     Document Type: Article

References (27)

1. C. Hansch, D. Hoekman, H. Gao, Chem. Rev. 1996, 96, 1045-1075.
2. J. Devillers (Ed.), Neural Networks in QSAR and Drug Design. Academic Press, San Diego 1996.
3. A. P. Borosy, K. Keseru, P. Matyus, Chemom. Intell. Lab. Syst. 2000, 54, 107-122.
4. C. Hansch, P. P. Maloney, T. Fujita, R. M. Muir, Nature 1962, 194, 178-180.
5. C. Hansch, T. Fujita, J. Am. Chem. Soc. 1964, 86, 5176-5179.
6. C. Hansch, Acc. Chem. Res. 1967, 2, 232-269.
7. C. Hansch, J. M. Clayton, J. Pharm. Sci. 1973, 62, 1-21.
8. C. Hansch, A. Leo, Substituent Constants for Correlation Analysis in Chemistry and Biology. Wiley, New York 1979.
9. M. W. W. Wolowyk, E. E. Knaus, in the Calcium Channel Modulators in Heart and Smooth Muscle: Basic Mechanisms and Pharmacological Aspects (Eds.: S. Abraham, G. Amitai) VCH, Weinheim, 1990.
10. R. Fossheim, J. Med. Chem. 1986, 29, 305-307.
11. G. H. Scholz, S. Vieweg, M. Uhlig, M. Thormann, P. Klossek, S. Goldmann, H.J. Hofmann, J. Med. Chem. 1997, 40, 1530-1538.
12. M. Mahmoudian, G. W. Richards, J. Pharm. Pharmacol. 1986, 38, 372-376.
13. F. E. Norrngton, R. M. Hyde, S. G. Williams, R. Wooton, J. Med. Chem. 1975, 18, 604-610.
14. G. Rovnyak, N. Anderson, J. Gougoutas, A. Hedberg, S. D. Kimball, M. Malley, S. Moreland, M. Porubcan, A. Pudzianowski, J. Med. Chem. 1991, 34, 2521-2525.
15. R. A. Cobrun, M. Weirzba, M. J. Suto, A. J. Solo, A. M. Triggle, D. J. Triggle, J. Med. Chem. 1988, 31, 2103-2107.
16. M. C. A. Costa, A. S. Gaudio, Y. Takahata, J. Mol. Struct. (THEOCHEM) 1997, 394-397.
17. M. Mahmoudian, W. G. Richards, J. Sci. I. R. Iran 1990, 1, 261-265.
18. M. C. A. Gaudio, A. Korolkovas, Y. Takahata, J. Pharm. Sci. 1994, 83, 1110-1115.
19. R. Shafiee, R. Miri, A. R. Dehpour, F. Solimani, Pharmaceut. Sci. 1996, 2, 541-543.
20. R. Miri, A. R. Dehpour, M. Azimi, A. Shafiee, Daru: Journal of the School of Pharmacy, Medicinal Science University of Tehran, 2001, 9, 40-44.
21. R. Miri, H. Niknahad, Gh. Vesal, A. Shafiee, Farmaco 2002, 57, 123-128.
22. R. Miri, S. E. Howlett, E. E. Knaus, Arch. Pharm. Pharm. Med. Chem. 1997, 330, 290-294.
23. R. Miri, H. Niknahad, A. Vazin, A. Azarpira, A. Shafiee, Daru: Journal of the School of Pharmacy, Medicinal Science University of Tehran, in press.
24. L. Navidpour, The Synthesis Pharmacological Effects of Some New Dihydropyridine Derivatives Containing 2-Phenylimidazolyl as Calcium Channel Antagonists, M. S. Thesis, Faculty of Pharmacy, Medicinal Science University of Tehran, Tehran, Iran 2000.
25. A. Shafiee, A. R. Dehpour, F. Hadizadeh, M. Azimi, Pharm. Acta Helv. 1998, 73, 75-79.
26. C. Hansch, A. J. Leo, R. W. Taft, Chem. Rev. 1991, 91, 165-195.
27. A. J. Leo, Chem. Rev. 1993, 93, 1981-1308.